← All stocks

ABEONA THERAPEUTICS INC.

ABEO Net selling
CIK 0000318306 #3433 in the set updated 18 Sep 2026
Bought (120 mo)
$1.56M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$10.86M
$1.06M on a plan · $861.57K straight out of an exercise
Sold at will
$8.94M
96 of 109 sales
Net
−$9.30M
−$7.38M against sales at will

By person

25 insiders · 129 transactions
11.5×

Vishwas Seshadri holds 11.5 times base salary in stock. $7.66M of shares against $662.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Vishwas Seshadri last reported holding, valued at $5.86, the price Common Stock was last bought or sold at on the open market here, on 1 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
SCO CAPITAL PARTNERS LLC entity
Director
$2.47M (11)
−$2.47M
11,079,292
19.37%
$64.97M
−8.3%
Seshadri Vishwas
Chief Executive Officer
$201.20K (3)
$2.52M (12)
−$2.32M
1,306,108
2.28%
$7.66M
Wider Todd
Director
$27.40K (1)
$1.54M (8)
−$1.51M
16,907
0.0296%
$99.15K
−51.6%
Buono Stefano
Director
$1.05M (3)
+$1.05M
287,969
0.5036%
$1.69M
Vazzano Joseph Walter
Chief Financial Officer
$39.07K (4)
$989.55K (12)
−$950.48K
492,079
0.8605%
$2.89M
Alvino Mark
Director
$641.27K (16)
−$641.27K
62,065
0.1085%
$363.97K
Mann Paul Elliot
Director
$569.62K (6)
−$569.62K
16,907
0.0296%
$99.15K
Silverstein Christine Berni
Director
$423.71K (5)
−$423.71K
119,562
0.2091%
$701.16K
O'Malley Brendan M.
SVP, Chief Legal Officer
$87.56K (4)
$505.71K (13)
−$418.15K
427,953
0.7484%
$2.51M
Crombez Eric
Director
$260.21K (3) scheduled
−$260.21K
37,313
0.0653%
$218.82K
Vasanthavada Madhav
Chief Commercial Officer
$239.06K (5)
−$239.06K
290,623
0.5082%
$1.70M
+14.1%
Amoroso Michael
Director
$161.63K (7)
−$161.63K
217,779
0.3808%
$1.28M
CARR EDWARD
Chief Financial Officer
$142.98K (4)
−$142.98K
400,169
0.6998%
$2.35M
Alland Leila
Director
$51.80K (1)
$185.32K (3)
−$133.52K
162,614
0.2844%
$953.63K
Wuchterl Donald A.
Director
$105.56K (2)
−$105.56K
167,935
0.2937%
$984.84K
Charles Faith L.
Director
$24.76K (1)
$103.80K (2)
−$79.04K
176,407
0.3085%
$1.03M
Van Duyne Richard B
Director
$46.26K (1)
+$46.26K
6,000
0.0105%
$35.19K
Howell Stephen B.
Director
$31.08K (1)
+$31.08K
97,463
0.1704%
$571.56K
+29.1%
Rouhandeh Steven H
Director
533,590
0.9331%
$3.13M
+42.3%
Ahn Mark J
Director
493,182
0.8624%
$2.89M
+43.7%
Siffert Joao MD
Chief Executive Officer
100,000
0.1749%
$586.44K
Zeiher Bernhardt G
Director
84,458
0.1477%
$495.30K
MIGAUSKY GEORGE V
Director
37,954
0.0664%
$222.58K
Tomasello Shawn
Director
35,938
0.0628%
$210.75K
Goldan Keith A.
Director
32,751
0.0573%
$192.06K
Insider
Date
Role
Action
Shares
Price
Amount
Mann Paul Elliot
19 Feb 2021
Director
Sold after exercise
45,566
$2.38
$108.50K
Wider Todd
18 Feb 2021
Director
Sold after exercise
1,345
$2.43
$3.27K
Wider Todd
17 Feb 2021
Director
Sold after exercise
320,000
$2.34
$749.79K

What was left out

Form 4 filings counted 281
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 10
Sales straight out of an exercise 3
Sales at will 96
Transactions with no price 0
Shares from compensation/vesting 10,551,935
Sales filed before the plan box existed 36
History held since 28 Sep 2016